SCHEMBL9044803

SCHEMBL9044803

C[CH]CCCc1c(C)cccc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.47
HPGD P15428 5/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
KDM4E B2RXH2 2/20 0.47
GPR52 Q9Y2T5 2/20 0.43
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 2/20 0.40
MEN1 O00255 1/20 0.40
AKR1B10 O60218 1/20 0.40
TRPA1 O75762 1/20 0.40
ABCB11 O95342 1/20 0.40
DHFR P00374 1/20 0.40
LMNA P02545 1/20 0.40
MPO P05164 1/20 0.40
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9048247 0.87 GPR52 (0.40) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9047365 0.84 TSHR (0.46) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9044047 0.84 CLCN2 (0.43) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9046010 0.84 ALB (0.45) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9046705 0.82 GABRA1 (0.41) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9045319 0.82 GPR52 (0.46) HPGDALDH1A1HSD17B10KDM4EGPR52
SCHEMBL6859420 0.81 KDM4E (0.52) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL11858599 0.81 ALDH1A1 (0.47) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL26679418 0.80 HSD17B10 (0.50) MYCHPGDALDH1A1HSD17B10KDM4E
SCHEMBL9045316 0.80 HPGD (0.50) MYCHPGDALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690854-A1 1-PHENYL-IMIDAZOL-2-ONE BIPHENYLMETHYL COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1996-01-10 EP disclosed